Skip to content

HyCON Labs

+1 (631) 210-5235

info@hyconlabs.com

  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
Home » Executive Summary

Executive Summary

Menu
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Scientist experimenting in Lab
Regulatory Support Services

Effective Risk Management and De-Risking Approaches for Early-Stage Pharmaceutical Development

Regulatory Support Services

This appraisal will intensively scrutinize the critical variables that must be meticulously considered and the formidable challenges that are invariably encountered during…

Read More Effective Risk Management and De-Risking Approaches for Early-Stage Pharmaceutical DevelopmentContinue

Image showing a scientific experiment
Oral Technology

Formulation Technologies for Small Molecule Drugs

Oral Technology

INTRODUCTION The development of new chemical entities (NCEs) has shifted in recent years toward smaller drug developers, creating a more varied market…

Read More Formulation Technologies for Small Molecule DrugsContinue

Image showing Tablet dissolving in water
Development & Bioavailability | Dosage Form Design | Oral Technology

How to Select an Optimal Formulation Strategy for Solubility

Development & Bioavailability, Dosage Form Design, Oral Technology

Why has solubility become a challenging aspect? The effectiveness of orally administered medicines hinges on the drug’s ability to dissolve in the gastrointestinal tract and promptly…

Read More How to Select an Optimal Formulation Strategy for SolubilityContinue

A scientist experimenting in a Hycon lab
Manufacturing

Strategies for Optimal Scale-up and Technology Transfer

Manufacturing

Introduction Overcoming drug development challenges requires a science-driven approach enhanced by data-driven decision-making and working with the right contract development and manufacturing…

Read More Strategies for Optimal Scale-up and Technology TransferContinue

Image showing scientist performing experiment
Development & Bioavailability

Strategies to Accelerate Your Molecule’s Development

Development & Bioavailability

INTRODUCTION The development of orally administered small molecules  is becoming more challenging as an increasing number  of molecules in pipelines have poor…

Read More Strategies to Accelerate Your Molecule’s DevelopmentContinue

Scientist performing pharmaceutical experiment
Development & Bioavailability

How To Create An Bioavailability Enhanced Formulation

Development & Bioavailability

Utilizing strategies that conserve active pharmaceutical ingredient (API) quantities and pinpointing scalable formulation technologies suitable for boosting drug solubility and augmenting oral…

Read More How To Create An Bioavailability Enhanced FormulationContinue

Medicine on a Table
Development & Bioavailability

Techniques for Choosing and Developing a Drug Candidate

Development & Bioavailability

Employing information regarding an active pharmaceutical ingredient’s physicochemical characteristics obtained from pre-formulation and formulation investigations enhances the probability of achieving success in…

Read More Techniques for Choosing and Developing a Drug CandidateContinue

Scientist experimenting in a pharma lab
Development & Bioavailability

Survey Reveals Orphan Drugs Companies are Hindered by Internal Limitations

Development & Bioavailability

Orphan drugs encounter challenges that extend from their initial discovery to eventual launch, primarily due to the restricted patient numbers and niche…

Read More Survey Reveals Orphan Drugs Companies are Hindered by Internal LimitationsContinue

Image of ISO Certified Organization
WHO - GMP Logo
Made in USA Logo
Logo of Current Good Manufacturing Practice
Certified Organization Logo
FDA Approved Icon
Seal of the United States Drug Enforcement Administration

Contact us today to start your project in 1 week!

Call +1 (631) 210-5235 to hit the ground running

Contact Us
HyCON Labs a premier small molecule CDMO, enabling pharmaceutical partners to slash development, and manufacturing costs and bring speed to market.
Youtube Linkedin
Services
  • Product Development
  • Processing Technologies
  • Clinical Trial Supply
  • Drug Product Manufacturing
  • Solutions by Phase
Explore
  • Dosage Forms
  • Formulation Technologies
  • Resources
  • About Us
  • Our Locations
Get In Touch

Phone No.: +1 631-210-5235

E-Mail ID: info@hyconlabs.com

© 2025 HyCON Labs Solutions. All Rights Reserved.